Rhumbline Advisers Castle Biosciences Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Castle Biosciences Inc stock. As of the latest transaction made, Rhumbline Advisers holds 40,901 shares of CSTL stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,901
Previous 41,896 2.37%
Holding current value
$1.09 Million
Previous $912,000 27.85%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$17.4 - $31.47 $17,313 - $31,312
-995 Reduced 2.37%
40,901 $1.17 Million
Q2 2024

Aug 01, 2024
BUY
$18.84 - $24.94 $56,293 - $74,520
2,988 Added 7.68%
41,896 $912,000
Q1 2024

May 09, 2024
BUY
$18.06 - $25.3 $18,060 - $25,300
1,000 Added 2.64%
38,908 $861,000
Q4 2023

Feb 08, 2024
BUY
$12.19 - $22.43 $731 - $1,345
60 Added 0.16%
37,908 $818,000
Q3 2023

Nov 09, 2023
BUY
$13.28 - $20.3 $7,157 - $10,941
539 Added 1.44%
37,848 $639,000
Q2 2023

Aug 08, 2023
SELL
$11.66 - $26.0 $23,156 - $51,636
-1,986 Reduced 5.05%
37,309 $511,000
Q1 2023

May 11, 2023
BUY
$19.47 - $28.49 $26,927 - $39,401
1,383 Added 3.65%
39,295 $893,000
Q4 2022

Feb 14, 2023
BUY
$18.08 - $30.0 $7,105 - $11,790
393 Added 1.05%
37,912 $892,000
Q3 2022

Nov 10, 2022
BUY
$22.51 - $34.32 $72,909 - $111,162
3,239 Added 9.45%
37,519 $978,000
Q2 2022

Aug 11, 2022
BUY
$16.0 - $45.99 $197,504 - $567,700
12,344 Added 56.27%
34,280 $752,000
Q1 2022

May 12, 2022
BUY
$33.17 - $46.98 $34,430 - $48,765
1,038 Added 4.97%
21,936 $984,000
Q4 2021

Feb 10, 2022
SELL
$39.06 - $67.58 $13,944 - $24,126
-357 Reduced 1.68%
20,898 $896,000
Q3 2021

Nov 12, 2021
BUY
$60.13 - $77.6 $50,028 - $64,563
832 Added 4.07%
21,255 $1.41 Million
Q2 2021

Aug 05, 2021
BUY
$50.07 - $76.78 $296,063 - $454,000
5,913 Added 40.75%
20,423 $1.5 Million
Q1 2021

May 06, 2021
BUY
$58.92 - $97.33 $59,332 - $98,011
1,007 Added 7.46%
14,510 $993,000
Q4 2020

Feb 10, 2021
BUY
$43.6 - $73.05 $44,777 - $75,022
1,027 Added 8.23%
13,503 $907,000
Q3 2020

Nov 12, 2020
SELL
$38.47 - $52.03 $11,079 - $14,984
-288 Reduced 2.26%
12,476 $642,000
Q2 2020

Aug 13, 2020
BUY
$27.28 - $43.01 $96,025 - $151,395
3,520 Added 38.08%
12,764 $481,000
Q1 2020

May 06, 2020
BUY
$23.08 - $35.53 $213,351 - $328,439
9,244 New
9,244 $276,000

Others Institutions Holding CSTL

# of Institutions
201
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $701M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email